Mauro Piantelli

Via Luigi Polacchi, 11
Chieti, 66100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

A bio-fortified whole tomato food supplement as potential dietary tool for the management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

A bio-fortified whole tomato food supplement as potential dietary tool for the management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Journal: Journal of translational medicine

Published: November 28, 2025

A step forward in enhancing the health-promoting properties of whole tomato as a functional food to lower the impact of non-communicable diseases.

A step forward in enhancing the health-promoting properties of whole tomato as a functional food to lower the impact of non-communicable diseases.

Journal: Frontiers in nutrition

Published: November 04, 2024

Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model.

Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model.

Journal: International journal of molecular sciences

Published: January 16, 2023

Development of the whole tomato and olive-based food supplement enriched with anti-platelet aggregating nutrients.

Development of the whole tomato and olive-based food supplement enriched with anti-platelet aggregating nutrients.

Journal: Nutrition and health

Published: October 27, 2022

Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion.

Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion.

Journal: Oncogene

Published: September 01, 2021

Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.

Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.

Journal: Neoplasia (New York, N.Y.)

Published: June 30, 2021

Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study.

Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study.

Journal: Journal of translational medicine

Published: September 01, 2020

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.

Journal: BMC cancer

Published: December 29, 2018

Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.

Secreted Gal-3BP is a novel promising target for non-internalizing Antibody-Drug Conjugates.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 16, 2018

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.

Journal: BMC cancer

Published: August 22, 2018

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.

Journal: Molecular oncology

Published: February 23, 2018

The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.

The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 29, 2017

Showing 1-12 of 44

Last Updated: 09/26/2026